Stockreport

Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting [Yahoo! Finance]

Revance Therapeutics, Inc.  (RVNC) 
Last revance therapeutics, inc. earnings: 2/24 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.revance.com
PDF patient-desired retreatment intervals and one abstract examining the influence of DAXXIFY's formulation on clinical performance NASHVILLE, Tenn., April 12, 2024 BUSINE [Read more]